IMA - ImageneBio Inc Stock Analysis | Stock Taper

SCREENER COMPARE ANY 2 STOCKS

IMA

IMAGENEBIO INC

NASDAQ

$5.34

▲ UP 0.19% (0.01)

KEY STATISTICS

Market Cap$60.23 M

52w High$13.98

52w Low$3.94

Dividend Yield—

Frequency—

P/E-1.05

Volume4.51K

Shares Out.11.28M

COMPANY

LEADERSHIP

Kristin Yarema

CHIEF EXECUTIVE

Kristin Yarema

COMPENSATION 2026

Salary$274,615

Stock Awards$1,312,468

Incentive Plan Pay$138,082

All Other Comp.$5,733

Total$8,171,198

ABOUT

SECTOR

Healthcare

WENT PUBLIC

February 27, 1998

METHOD OF GOING PUBLIC

IPO

FULL TIME EMPLOYEES

18

PRICE TARGET

Target High$1.33

Target Low$1.33

Target Median$1.33

Target Consensus$1.33

UPCOMING EARNINGS

DateNov 11, 2026

DayWednesday

Rev. Est.—

NOV

11

WED

SPLIT RECORD

DATE	TYPE	RATIO
2025-07-28	Reverse	1:12

PRICE

$5.34 ▲ UP 0.19% (+$0.01)

OVERLAYS

About ImageneBio Inc

https://www.inmagenebio.com ↗

Clinical-stage biotechnology company developing differentiated therapies for immunological/autoimmune & inflammatory (I&I) diseases, notably non‑depleting anti‑OX40 monoclonal antibody IMG‑007 in Phase 2b for atopic dermatitis

INDUSTRY

Biotechnology

A PRODUCT IMAGENEBIO INC IS KNOWN FOR

IMG-007

IMG-007 is a clinical-stage, non-depleting anti-OX40 antibody in Phase 2b trials for atopic dermatitis and alopecia areata, serving as ImageneBio's lead asset post-merger and financing.

COMPETITORS

COMPETITOR

ETFS HOLDING THIS STOCK

ETFS HOLDING

12

LISTED HERE

2

RANKED BY POSITION SIZE

INSTITUTIONAL OWNERSHIP

SHARES OWNED

45.72%

HOLDERS

43

TOP 12 OF 43 · RANKED BY POSITION SIZE

1.1M sh · $5.55M

Blue Owl Capital Holdings LP

959.3K sh · $4.8M

Cable Car Capital LLC

754.7K sh · $3.77M

Omega Fund Management, LLC

455.4K sh · $2.28M

Orbimed Advisors LLC

378.6K sh · $1.89M

Atlas Venture Life Science Advisors, LLC

377.8K sh · $3.08M

Rtw Investments, LP

334.4K sh · $1.67M

Vanguard Group Inc

238.0K sh · $1.64M

Bml Capital Management, LLC

200.7K sh · $1M

Blackrock, Inc.

131.6K sh · $907.95K

Citadel Advisors LLC

124.3K sh · $621.73K

Monashee Investment Management LLC

91.6K sh · $632.18K

RATINGS SNAPSHOT

Overall rating: B-

Discounted Cash Flow4

Return On Equity1

Return On Assets1

Debt To Equity4

Price To Earnings1

Price To Book4

Overall Score3

INSIDER TRADES

★

DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER

Yarema Kristin

Purchase · 137.2K shares

2026-08-14

★

OFFICER: CHIEF FINANCIAL OFFICER

Grant-Huerta Yanina

Purchase · 56.0K shares

2026-08-14

★

DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER

Yarema Kristin

Purchase · 254.8K shares

2026-08-14

★

DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER

Yarema Kristin

Purchase · 250.0K shares

2026-08-14

MOST RECENT ANALYST GRADES

GRADE SUMMARY

UNDERPERFORM 1

1 GRADES IN THE LAST 12 MONTHS

Wedbush UNDERPERFORM

SECTORS PEERS

PEER	PRICE
STTK	$7.04	COMPARE
ARTV	$11.09	COMPARE
OVID	$2.80	COMPARE
IFRX	$2.23	COMPARE
STRO	$20.45	COMPARE
CNTB	$2.23	COMPARE
KLRS	$4.03	COMPARE
MGX	$1.19	COMPARE